Are adipokines associated with atrial fibrillation in type 2 diabetes?
Michał PellerAgnieszka Kapłon-CieślickaMarek RosiakAgata TymińskaKrzysztof OzierańskiCeren EyiletenAgnieszka KondrackaDagmara Mirowska-GuzelGrzegorz OpolskiMarek PostułaKrzysztof J FilipiakPublished in: Endokrynologia Polska (2021)
In type 2 DM, patients with AF have higher resistin and adiponectin concentrations than patients with no AF. None of the studied adipokines proved a predictor of future AF development.
Keyphrases
- atrial fibrillation
- type diabetes
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- heart failure
- insulin resistance
- glycemic control
- metabolic syndrome
- percutaneous coronary intervention
- cardiovascular disease
- current status
- adipose tissue
- venous thromboembolism
- coronary artery disease